Search results
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks· 15 hours agoShares of COVID-19 vaccine developers rose on Monday after the FDA issued briefing documents for its Vaccines and ...
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 7 hours agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
Will there be new COVID-19 booster for fall 2024?
WCVB Boston· 4 days agoWill there be new COVID-19 booster for fall 2024?
US FDA advisers to consider if new COVID shots should target JN.1 variant By Reuters
Investing.com· 1 day agoThe company had said last month it would only be able to offer aCOVID vaccine in the United States...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 1 day agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
Trending tickers: Berkshire Hathaway, Nvidia, Novavax and Adani Enterprises
Yahoo Finance UK· 11 hours agoShares soared 21% during the...FCA announcement. The company had said last month it would only be...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 6 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 1 day agoFriday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for its...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 4 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 7 days agoThe updated monovalent XBB.1.5 COVID-19 vaccines were effective against Omicron subvariants circulating during the most recent respiratory virus season,...